Vinpocetine for Health & Longevity - Quick Reference Sheet
evipedia.ai ← Back

Vinpocetine for Health & Longevity

Created on 06/18/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 4.8 – Audit

Vinpocetine is a periwinkle-derived compound used abroad to improve brain blood flow and ease age-related memory complaints. Its clearest action is measurably increasing brain blood flow; benefits for memory and stroke recovery remain uncertain, and longevity claims rest mainly on lab work. Avoid entirely during pregnancy. Supplement quality is inconsistent. (Full Review)

Protocol

Dose
5–10 mg 3×/day
Totaling 15–30 mg per day, with meals
Schedule
Divided doses
Short half-life (~1–2 h); thrice daily, not a single dose
Administration
Take with food
Low bioavailability; absorption improves substantially with meals
Time to effect
Cerebral blood flow
Within hours
Acute blood-flow changes after dosing
Symptom/cognitive benefit
4–12 weeks
Requires weeks of consistent use

Benefits

Contraindications
  • Pregnant, attempting to conceive, or of childbearing potential without reliable contraception
  • Active bleeding or bleeding disorders
  • Surgery scheduled within ~2 weeks
  • Significant hypotension
  • Children and adolescents
    •
Key Interactions
  • Anticoagulants and antiplatelet drugs (warfarin, apixaban, rivaroxaban, clopidogrel, aspirin)
  • Antihypertensive medications (amlodipine, lisinopril, metoprolol)
  • Over-the-counter NSAIDs (ibuprofen, naproxen, aspirin)
  • Supplements with antiplatelet/blood-thinning effects (fish oil/EPA & DHA, Ginkgo biloba, garlic extract, high-dose vitamin E, nattokinase)
  • Supplements with additive blood-pressure-lowering effects (other cerebral vasodilators, high-dose nitrate-rich supplements)
    •

Risk & Side Effects

  • High:
  • Medium: Use during pregnancy and in women of childbearing potential
    •
  • Low: Common mild adverse effects; bleeding risk and antiplatelet effect
    •
  • Speculative: Unregulated supplement quality and dose variability; immune and hematologic signals
    •

Monitoring

Marker Target Why
Blood pressure ~110–125 / 70–80 mmHg Vinpocetine can lower blood pressure via vasodilation
Heart rate 55–70 bpm resting Detects vasodilation-related reflex changes
INR (if on warfarin) 2.0–3.0 (per indication) Antiplatelet/blood-thinning interaction may raise bleeding risk
Complete blood count (CBC) Within normal limits; platelets ~200–400 ×10⁹/L Screens for rare blood-count effects and baseline platelet status
hs-CRP (high-sensitivity C-reactive protein) <1.0 mg/L Tracks vascular inflammation, the theoretical target of the anti-inflammatory mechanism
Pregnancy test (βhCG) Negative (if applicable) Confirms absence of pregnancy given FDA advisory

Cadence: Baseline before starting; blood pressure at 1–2 weeks after starting and after dose changes; coagulation parameters every 6–12 months only in those on blood thinners or with bleeding risk

Qualitative Assessment

  • Subjective memory and word recall in daily life
  • Mental clarity, focus, and processing speed
  • Energy and alertness levels through the day
  • Dizziness, lightheadedness, or flushing (tolerability signals)
  • Sleep quality, especially if dosing late in the day
  • Headache frequency or change
Not medical advice. Educational distillation of a single evidence review. Confirm any decision with a qualified clinician, especially in the presence of prescription drugs or chronic conditions.